{"entity":{"type":"insider","cik":"0001772259","url":"/insider/0001772259","json_url":"/insider/0001772259.json","name":"Cui Jingrong Jean","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":179,"n_filings":21,"first":"2019-12-09","last":"2020-06-10","span_basis":"filed_date"},"name_variants":[{"name":"Cui Jingrong Jean","source":"filing","n_filings":21,"first_seen":"2019-12-09","last_seen":"2020-06-10"}],"transactions":[{"id":2076646,"accession":"0001209191-20-035621","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-035621","line_url":"/filing/0001209191-20-035621","is_derivative":false,"issuer_cik":"0001595893","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595893","owner_cik":"0001772259","owner_name":"Cui Jingrong Jean","owner_display_name":"Cui Jingrong Jean","owner_url":"/insider/0001772259","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9500.0,"shares_display":"9,500","price_per_share":65.80986947368422,"price_display":"65.81","price_state":"stated","total_value":625193.76,"total_display":"625,193.76","total_whole":"625,194","shares_owned_after":543268.0,"shares_owned_after_display":"543,268","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-09","filed_date":"2020-06-10","scope":"insider","n_lines":5},{"id":2544692,"accession":"0001209191-20-035149","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-20-035149","line_url":"/filing/0001209191-20-035149","is_derivative":false,"issuer_cik":"0001595893","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595893","owner_cik":"0001772259","owner_name":"Cui Jingrong Jean","owner_display_name":"Cui Jingrong Jean","owner_url":"/insider/0001772259","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18500.0,"shares_display":"18,500","price_per_share":63.45341837837838,"price_display":"63.45","price_state":"stated","total_value":1173888.24,"total_display":"1,173,888.24","total_whole":"1,173,888","shares_owned_after":555844.0,"shares_owned_after_display":"555,844","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-08","filed_date":"2020-06-08","scope":"insider","n_lines":3},{"id":2544684,"accession":"0001209191-20-035149","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-20-035149","line_url":"/filing/0001209191-20-035149","is_derivative":false,"issuer_cik":"0001595893","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595893","owner_cik":"0001772259","owner_name":"Cui Jingrong Jean","owner_display_name":"Cui Jingrong Jean","owner_url":"/insider/0001772259","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18500.0,"shares_display":"18,500","price_per_share":64.20909675675675,"price_display":"64.21","price_state":"stated","total_value":1187868.29,"total_display":"1,187,868.29","total_whole":"1,187,868","shares_owned_after":574354.0,"shares_owned_after_display":"574,354","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-05","filed_date":"2020-06-08","scope":"insider","n_lines":4},{"id":2544677,"accession":"0001209191-20-035149","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-20-035149","line_url":"/filing/0001209191-20-035149","is_derivative":false,"issuer_cik":"0001595893","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595893","owner_cik":"0001772259","owner_name":"Cui Jingrong Jean","owner_display_name":"Cui Jingrong Jean","owner_url":"/insider/0001772259","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18500.0,"shares_display":"18,500","price_per_share":64.8049318918919,"price_display":"64.80","price_state":"stated","total_value":1198891.24,"total_display":"1,198,891.24","total_whole":"1,198,891","shares_owned_after":592183.0,"shares_owned_after_display":"592,183","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-04","filed_date":"2020-06-08","scope":"insider","n_lines":8},{"id":2831986,"accession":"0001209191-20-031506","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-20-031506","line_url":"/filing/0001209191-20-031506","is_derivative":false,"issuer_cik":"0001595893","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595893","owner_cik":"0001772259","owner_name":"Cui Jingrong Jean","owner_display_name":"Cui Jingrong Jean","owner_url":"/insider/0001772259","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":59.65,"price_display":"59.65","price_state":"stated","total_value":417550.0,"total_display":"417,550.00","total_whole":"417,550","shares_owned_after":605483.0,"shares_owned_after_display":"605,483","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-21","filed_date":"2020-05-21","scope":"insider","n_lines":2},{"id":2831983,"accession":"0001209191-20-031506","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-031506","line_url":"/filing/0001209191-20-031506","is_derivative":false,"issuer_cik":"0001595893","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595893","owner_cik":"0001772259","owner_name":"Cui Jingrong Jean","owner_display_name":"Cui Jingrong Jean","owner_url":"/insider/0001772259","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":60.14928571428572,"price_display":"60.15","price_state":"stated","total_value":421045.0,"total_display":"421,045.00","total_whole":"421,045","shares_owned_after":613783.0,"shares_owned_after_display":"613,783","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-20","filed_date":"2020-05-21","scope":"insider","n_lines":3},{"id":2831976,"accession":"0001209191-20-031506","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-031506","line_url":"/filing/0001209191-20-031506","is_derivative":false,"issuer_cik":"0001595893","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595893","owner_cik":"0001772259","owner_name":"Cui Jingrong Jean","owner_display_name":"Cui Jingrong Jean","owner_url":"/insider/0001772259","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":57.72971428571429,"price_display":"57.73","price_state":"stated","total_value":404108.0,"total_display":"404,108.00","total_whole":"404,108","shares_owned_after":619783.0,"shares_owned_after_display":"619,783","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-19","filed_date":"2020-05-21","scope":"insider","n_lines":4},{"id":2469106,"accession":"0001209191-20-028675","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-028675","line_url":"/filing/0001209191-20-028675","is_derivative":false,"issuer_cik":"0001595893","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595893","owner_cik":"0001772259","owner_name":"Cui Jingrong Jean","owner_display_name":"Cui Jingrong Jean","owner_url":"/insider/0001772259","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11500.0,"shares_display":"11,500","price_per_share":53.856626086956524,"price_display":"53.86","price_state":"stated","total_value":619351.2,"total_display":"619,351.20","total_whole":"619,351","shares_owned_after":631233.0,"shares_owned_after_display":"631,233","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-08","filed_date":"2020-05-12","scope":"insider","n_lines":4},{"id":2110346,"accession":"0001209191-20-027784","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-20-027784","line_url":"/filing/0001209191-20-027784","is_derivative":false,"issuer_cik":"0001595893","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595893","owner_cik":"0001772259","owner_name":"Cui Jingrong Jean","owner_display_name":"Cui Jingrong Jean","owner_url":"/insider/0001772259","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18500.0,"shares_display":"18,500","price_per_share":52.85867675675676,"price_display":"52.86","price_state":"stated","total_value":977885.52,"total_display":"977,885.52","total_whole":"977,886","shares_owned_after":639213.0,"shares_owned_after_display":"639,213","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-07","filed_date":"2020-05-07","scope":"insider","n_lines":3},{"id":2110341,"accession":"0001209191-20-027784","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-027784","line_url":"/filing/0001209191-20-027784","is_derivative":false,"issuer_cik":"0001595893","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595893","owner_cik":"0001772259","owner_name":"Cui Jingrong Jean","owner_display_name":"Cui Jingrong Jean","owner_url":"/insider/0001772259","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18500.0,"shares_display":"18,500","price_per_share":52.936352432432436,"price_display":"52.94","price_state":"stated","total_value":979322.52,"total_display":"979,322.52","total_whole":"979,323","shares_owned_after":656383.0,"shares_owned_after_display":"656,383","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-06","filed_date":"2020-05-07","scope":"insider","n_lines":2},{"id":2110338,"accession":"0001209191-20-027784","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-027784","line_url":"/filing/0001209191-20-027784","is_derivative":false,"issuer_cik":"0001595893","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595893","owner_cik":"0001772259","owner_name":"Cui Jingrong Jean","owner_display_name":"Cui Jingrong Jean","owner_url":"/insider/0001772259","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18500.0,"shares_display":"18,500","price_per_share":54.02302162162162,"price_display":"54.02","price_state":"stated","total_value":999425.9,"total_display":"999,425.90","total_whole":"999,426","shares_owned_after":680667.0,"shares_owned_after_display":"680,667","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-05","filed_date":"2020-05-07","scope":"insider","n_lines":3},{"id":2218632,"accession":"0001209191-20-025731","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-20-025731","line_url":"/filing/0001209191-20-025731","is_derivative":false,"issuer_cik":"0001595893","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595893","owner_cik":"0001772259","owner_name":"Cui Jingrong Jean","owner_display_name":"Cui Jingrong Jean","owner_url":"/insider/0001772259","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":51.01282428571429,"price_display":"51.01","price_state":"stated","total_value":357089.77,"total_display":"357,089.77","total_whole":"357,090","shares_owned_after":693683.0,"shares_owned_after_display":"693,683","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-04-24","filed_date":"2020-04-24","scope":"insider","n_lines":3},{"id":2218619,"accession":"0001209191-20-025731","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-025731","line_url":"/filing/0001209191-20-025731","is_derivative":false,"issuer_cik":"0001595893","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595893","owner_cik":"0001772259","owner_name":"Cui Jingrong Jean","owner_display_name":"Cui Jingrong Jean","owner_url":"/insider/0001772259","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":51.91542857142857,"price_display":"51.92","price_state":"stated","total_value":363408.0,"total_display":"363,408.00","total_whole":"363,408","shares_owned_after":704183.0,"shares_owned_after_display":"704,183","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-04-23","filed_date":"2020-04-24","scope":"insider","n_lines":4},{"id":2218599,"accession":"0001209191-20-025731","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-025731","line_url":"/filing/0001209191-20-025731","is_derivative":false,"issuer_cik":"0001595893","issuer_name":"Turning Point Therapeutics, Inc.","issuer_ticker":"TPTX","issuer_name_source":null,"issuer_url":"/issuer/0001595893","owner_cik":"0001772259","owner_name":"Cui Jingrong Jean","owner_display_name":"Cui Jingrong Jean","owner_url":"/insider/0001772259","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":51.783,"price_display":"51.78","price_state":"stated","total_value":362481.0,"total_display":"362,481.00","total_whole":"362,481","shares_owned_after":708683.0,"shares_owned_after_display":"708,683","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-04-22","filed_date":"2020-04-24","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2020-04-22|2218596","ledger_fault":false,"count":{"value":179,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":179,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":179},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001595893","name":"Turning Point Therapeutics, Inc.","url":"/issuer/0001595893","role":"Director, Officer (Chief Scientific Officer)","n_filings":21,"first_seen":"2019-12-09","last_seen":"2020-06-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001772259","retrieved_at":"2026-08-26T11:10:29+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}